Donna Reynolds (Task Force)
Due to the COVID-19 pandemic, the Task Force held its February 2022 meeting online via videoconference. Dr. Grad opened the meeting, and the Task Force members approved the agenda. Dr. Grad welcomed the new staff members of the Task Force. He also announced the upcoming departure of John Riva who has completed his term as a member.
Ms. Beckett, from the Knowledge Translation (KT) team provided updates on recent KT activities and initiatives. This update included information on recently published guidelines, new and upcoming KT tools, dissemination activities and Task Force projects involving KT and the annual evaluation.
Ms. Pillay discussed the KQ1 summary of findings format (NMA) and sought feedback from the Task Force.
Ms. Limburg presented an overview of the Topics WG projects, an update on cognitive impairment reaffirmation as well as an update on topic prioritization and options for the CVD framework components.
Ms. Pillay provided a status update and presented an overview of results for KQs 2, 3 and 5.
Dr. Thériault provided an update and sought input from the Task Force for the definition of “standard of care” and its application to the Fragility Fractures guideline.
Dr. Abou-Setta presented a proposal to halt the opioid guideline (and establish methods for future guidelines) for the Task Force’s review and approval.
Dr. Klarenbach provided an update and sought the Task Force’s approval for KQ3 and its PICO, as well as for a modified KQ1 and its PICO.
Mr. Traversy and Dr. Thombs proposed a recommendation structure and an EtD for pharmacotherapy.
The guideline working group chairs provided brief updates for each guideline.
Dr. Grad thanked everyone for attending. He floated the idea of the June 2022 meeting being face-to-face or hybrid in Calgary. The February 2022 Task Force virtual meeting was adjourned.